drugset / Trial / NCT00372697
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluated the safety and efficacy of an increased frequency of octreotide acetate injections or an increase in dose in partially responsive acromegalic patients with persistently uncontrolled disease.
Timeline
- Start
- 2005-12
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Octreotide | Peptide | 30 mg | Intramuscular |
| Subject | Octreotide | Peptide | 60 mg | Intramuscular |